Paris, December 1st 2017
Ennov announces the acquisition of AtEvent, publisher of the Atrium™ software suite for professional event and scientific congress management.
This acquisition strengthens Ennov’s leading position in regulated content management for Life Sciences.
AtEvent’s Atrium solution manages the transparency of interests between professionals and health industries (Human, Animal Health, Cosmetics and Medical Device) and thus ensures its customers regulatory compliance with all elements required by supervisory authorities (NOO/DMOS, EFPIA, Sunshine Act, Bertrand Law).
AtEvent becomes the Events division of Ennov. It complements the solutions that Ennov already proposes for quality management, regulatory affairs, pharmacovigilance and clinical trials.
Ennov designs, develops and distributes EDM and workflow software for the life sciences industry. The Ennov solution encompasses 4 main areas: clinical trials, regulatory affairs, pharmacovigilance and quality. Its customers include Air Liquide, Baxter, Ceva, MSD, Novartis and Virbac. Ennov is ISO 9001:2015 certified. For further details see www.ennov.com.
Created in June 2009, AtEvent is the fruit of operational reflection and observation, enriched by a long business expertise in the management of events in the pharmaceutical industry. AtEvent offers healthcare industries a collaborative platform for managing events and a business response, adapted to regulatory constraints (DMOS and Transparency). For further details see www.atevent.eu.
Download the complete press release.